DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 063208
describes CEFAZOLIN SODIUM
, which is a drug marketed by Acs Dobfar, Facta Farma, West-ward Pharms Int, Steri Pharma, Teva Pharms, Hospira Inc, Sandoz, Glaxosmithkline, Samson Medcl, Hikma Farmaceutica, Qilu Pharm Co Ltd, Fresenius Kabi Usa, Cephazone Pharma, Abraxis Pharm, Watson Labs Inc, Bedford, and Aurobindo Pharma, and is included in thirty-one NDAs. It is available from seventeen suppliers. Additional details are available on the CEFAZOLIN SODIUM profile page.
The generic ingredient in CEFAZOLIN SODIUM is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
Summary for NDA: 063208
|Formulation / Manufacturing:||see details|Complete Access Available with Subscription
Summary for product number 001
|Active Rx/OTC/Discontinued:||DISCN||Dosage:||INJECTABLE;INJECTION||Strength||EQ 1GM BASE/VIAL|
|Approval Date:||Dec 27, 1991||TE:||RLD:||No|
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.